• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用NAFX来测量基因疗法对犬类莱伯先天性黑蒙症随时间推移的有效性。

Using the NAFX to measure the effectiveness over time of gene therapy in canine LCA.

作者信息

Jacobs Jonathan B, Dell'Osso Louis F, Wang Zhong I, Acland Gregory M, Bennett Jean

机构信息

Daroff-Dell'Osso Ocular Motility Laboratory, Veterans Affairs Medical Center, Cleveland, OH 44106, USA.

出版信息

Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4685-92. doi: 10.1167/iovs.09-3387. Epub 2009 May 20.

DOI:10.1167/iovs.09-3387
PMID:19458334
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2849152/
Abstract

PURPOSE

To use ocular motility recordings to determine the changes over time of infantile nystagmus syndrome (INS) in RPE65-deficient canines with Leber Congenital Amaurosis (LCA) and assess the time course of the recalibration of the ocular motor system (OMS).

METHODS

Nine dogs were treated bilaterally with AAV-RPE65. A second cohort of four dogs was treated with AAV2.RPE65, an optimized vector. Their fixation eye movements were recorded before treatment and at 4-week intervals for 3 months, by using high-speed (500 Hz) digital videography. The dogs were suspended in a sling and encouraged to fixate on distant (57 inches) targets at gaze angles varying between +/-15 degrees horizontally and +/-10 degrees vertically. The records for each eye were examined for qualitative changes in waveform and for quantitative changes in centralisation with the expanded nystagmus acuity function (NAFX) and compared with ERG results for restoration of receptor function.

RESULTS

First group: Before treatment, five of the dogs had clinically apparent INS with jerk, pendular, or both waveforms and with peak-to-peak amplitudes as great as 15 degrees . One dog had intermittent nystagmus. At the 1- and 2-month examinations, no change in nystagmus waveform or NAFX was observed in any of the initial dogs, while at 10 weeks, one dog treated bilaterally with the standard dosage showed reduced nystagmus in only one eye. The other eye did not respond to treatment, as confirmed by ERG. This result was unexpected since it was previously documented that unilateral treatment leads to bilateral reduction of INS. The other dog treated with the standard dosage showed no reduction of its small-amplitude, high-frequency pendular nystagmus despite positive ERG responses. Second group: Only one dog of the four had clinically detectable INS, similar in characteristics to that seen in the affected dogs of the first group. Unlike any previous dog studied, this one showed a damping of the nystagmus within the first 4 weeks after treatment.

CONCLUSIONS

In all but one of the cases in which OMS recalibration occurred, as measured by the clinical appearance of nystagmus and by quantitative measurement using the NAFX, the improvement was apparent no sooner than 10 weeks after treatment. Longer term, dose-related studies are needed to determine the minimum necessary degree of restored receptor functionality, the duration after rescue for recalibration of the OMS, and the conditions under which recalibration information can successfully affect the contralateral eye.

摘要

目的

利用眼球运动记录来确定患有莱伯先天性黑蒙(LCA)的RPE65缺陷犬的婴儿型眼球震颤综合征(INS)随时间的变化,并评估眼球运动系统(OMS)重新校准的时间进程。

方法

对9只犬进行双侧AAV-RPE65治疗。第二组4只犬接受了优化载体AAV2.RPE65的治疗。在治疗前以及治疗后3个月内每隔4周,通过高速(500Hz)数字摄像记录它们的注视眼动。将犬悬吊在吊带中,鼓励它们注视远处(57英寸)的目标,水平注视角度在±15度之间变化,垂直注视角度在±10度之间变化。检查每只眼睛的记录,观察波形的定性变化以及使用扩展的眼球震颤视力功能(NAFX)评估注视中心的定量变化,并与视网膜电图(ERG)结果进行比较,以评估受体功能的恢复情况。

结果

第一组:治疗前,5只犬临床上表现出明显的INS,具有急跳、摆动或两种波形,峰峰值幅度高达15度。1只犬有间歇性眼球震颤。在1个月和2个月的检查中,最初的任何一只犬的眼球震颤波形或NAFX均未观察到变化,而在10周时,1只接受标准剂量双侧治疗的犬仅一只眼睛的眼球震颤有所减轻。视网膜电图证实,另一只眼睛对治疗无反应。这一结果出乎意料,因为之前有文献记载单侧治疗会导致INS双侧减轻。另一只接受标准剂量治疗的犬尽管视网膜电图反应呈阳性,但其小幅度、高频摆动性眼球震颤并未减轻。第二组:4只犬中只有1只临床上可检测到INS,其特征与第一组受影响的犬相似。与之前研究的任何犬不同,这只犬在治疗后的前4周内眼球震颤出现了衰减。

结论

除1例之外,在所有通过眼球震颤的临床表现和使用NAFX进行定量测量来衡量OMS重新校准的病例中,改善在治疗后10周之前均未明显显现。需要进行更长期的、与剂量相关的研究,以确定恢复受体功能所需的最低必要程度、OMS重新校准在挽救后持续的时间,以及重新校准信息能够成功影响对侧眼的条件。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01c9/2849152/eee6d27ae032/nihms151518f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01c9/2849152/300b7adc5a4a/nihms151518f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01c9/2849152/aaef29d76681/nihms151518f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01c9/2849152/11c5ab0bbd75/nihms151518f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01c9/2849152/34873e1b6c17/nihms151518f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01c9/2849152/bee58e452eed/nihms151518f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01c9/2849152/82a4c2d3354a/nihms151518f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01c9/2849152/eee6d27ae032/nihms151518f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01c9/2849152/300b7adc5a4a/nihms151518f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01c9/2849152/aaef29d76681/nihms151518f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01c9/2849152/11c5ab0bbd75/nihms151518f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01c9/2849152/34873e1b6c17/nihms151518f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01c9/2849152/bee58e452eed/nihms151518f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01c9/2849152/82a4c2d3354a/nihms151518f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/01c9/2849152/eee6d27ae032/nihms151518f7.jpg

相似文献

1
Using the NAFX to measure the effectiveness over time of gene therapy in canine LCA.使用NAFX来测量基因疗法对犬类莱伯先天性黑蒙症随时间推移的有效性。
Invest Ophthalmol Vis Sci. 2009 Oct;50(10):4685-92. doi: 10.1167/iovs.09-3387. Epub 2009 May 20.
2
Eye movement recordings as an effectiveness indicator of gene therapy in RPE65-deficient canines: implications for the ocular motor system.眼动记录作为RPE65基因缺陷犬基因治疗有效性的指标:对眼动系统的影响
Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2865-75. doi: 10.1167/iovs.05-1233.
3
Functional and structural recovery of the retina after gene therapy in the RPE65 null mutation dog.RPE65基因无效突变犬基因治疗后视网膜的功能和结构恢复
Invest Ophthalmol Vis Sci. 2003 Apr;44(4):1663-72. doi: 10.1167/iovs.02-0595.
4
Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer.使用优化的腺相关病毒2(AAV2)介导的基因转移在莱伯先天性黑蒙动物模型中恢复视力
Mol Ther. 2008 Mar;16(3):458-65. doi: 10.1038/sj.mt.6300389. Epub 2008 Jan 22.
5
Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness.在儿童失明犬模型中,通过单剂量重组腺相关病毒介导的基因转移至视网膜实现视杆和视锥视觉的长期恢复。
Mol Ther. 2005 Dec;12(6):1072-82. doi: 10.1016/j.ymthe.2005.08.008. Epub 2005 Oct 14.
6
Gene therapy in the second eye of RPE65-deficient dogs improves retinal function.RPE65 缺陷型犬的第二只眼的基因治疗可改善视网膜功能。
Gene Ther. 2011 Jan;18(1):53-61. doi: 10.1038/gt.2010.111. Epub 2010 Aug 12.
7
Safety in nonhuman primates of ocular AAV2-RPE65, a candidate treatment for blindness in Leber congenital amaurosis.眼部AAV2-RPE65在非人灵长类动物中的安全性,一种用于治疗莱伯先天性黑蒙失明的候选疗法。
Hum Gene Ther. 2006 Aug;17(8):845-58. doi: 10.1089/hum.2006.17.845.
8
An expanded nystagmus acuity function: intra- and intersubject prediction of best-corrected visual acuity.扩展的眼球震颤视力函数:个体内和个体间对最佳矫正视力的预测
Doc Ophthalmol. 2002 May;104(3):249-76. doi: 10.1023/a:1015299930849.
9
Restoration of vision in RPE65-deficient Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.使用一种专门靶向视网膜色素上皮的腺相关病毒4型载体恢复RPE65缺陷型布里犬的视力。
Gene Ther. 2007 Feb;14(4):292-303. doi: 10.1038/sj.gt.3302861. Epub 2006 Oct 5.
10
Gene therapeutic prospects in early onset of severe retinal dystrophy: restoration of vision in RPE65 Briard dogs using an AAV serotype 4 vector that specifically targets the retinal pigmented epithelium.严重视网膜营养不良早期发病的基因治疗前景:使用特异性靶向视网膜色素上皮的腺相关病毒血清型4载体恢复RPE65 Briard犬的视力。
Bull Mem Acad R Med Belg. 2006;161(10-12):497-508; discussion 508-9.

引用本文的文献

1
Lessons Learned from the Development of the First FDA-Approved Gene Therapy Drug, Voretigene Neparvovec-rzyl.从首个获得 FDA 批准的基因治疗药物(Voretigene Neparvovec-rzyl)的研发中汲取的经验教训。
Cold Spring Harb Perspect Med. 2023 May 2;13(5):a041307. doi: 10.1101/cshperspect.a041307.
2
Training pet dogs for eye-tracking and awake fMRI.训练宠物狗进行眼动追踪和清醒 fMRI 研究。
Behav Res Methods. 2020 Apr;52(2):838-856. doi: 10.3758/s13428-019-01281-7.
3
Development of an optimized AAV2/5 gene therapy vector for Leber congenital amaurosis owing to defects in RPE65.针对因RPE65缺陷导致的莱伯先天性黑蒙症,开发一种优化的AAV2/5基因治疗载体。
Gene Ther. 2016 Dec;23(12):857-862. doi: 10.1038/gt.2016.66. Epub 2016 Sep 22.
4
Oculomotor neurocircuitry, a structural connectivity study of infantile nystagmus syndrome.动眼神经回路,婴儿眼球震颤综合征的结构连接性研究。
PLoS One. 2015 Apr 10;10(4):e0125380. doi: 10.1371/journal.pone.0125380. eCollection 2015.
5
Dog models for blinding inherited retinal dystrophies.致盲性遗传性视网膜营养不良的犬模型
Hum Gene Ther Clin Dev. 2015 Mar;26(1):15-26. doi: 10.1089/humc.2014.155. Epub 2015 Feb 11.
6
Measurement of distance objective visual acuity with the computerized optokinetic nystagmus test in patients with ocular diseases.用电脑视动性眼震检查测量眼病患者的远距离客观视力。
Graefes Arch Clin Exp Ophthalmol. 2011 Sep;249(9):1379-85. doi: 10.1007/s00417-011-1705-x. Epub 2011 May 21.
7
Safety and efficacy of subretinal readministration of a viral vector in large animals to treat congenital blindness.在大型动物中重新经视网膜下给药病毒载体治疗先天性失明的安全性和有效性。
Sci Transl Med. 2010 Mar 3;2(21):21ra16. doi: 10.1126/scitranslmed.3000659.

本文引用的文献

1
Extraocular proprioception and new treatments for infantile nystagmus syndrome.眼外本体感觉与婴儿型眼球震颤综合征的新疗法
Prog Brain Res. 2008;171:67-75. doi: 10.1016/S0079-6123(08)00610-9.
2
Safety and efficacy of gene transfer for Leber's congenital amaurosis.基因转移治疗莱伯先天性黑蒙的安全性和有效性。
N Engl J Med. 2008 May 22;358(21):2240-8. doi: 10.1056/NEJMoa0802315. Epub 2008 Apr 27.
3
Reversal of blindness in animal models of leber congenital amaurosis using optimized AAV2-mediated gene transfer.使用优化的腺相关病毒2(AAV2)介导的基因转移在莱伯先天性黑蒙动物模型中恢复视力
Mol Ther. 2008 Mar;16(3):458-65. doi: 10.1038/sj.mt.6300389. Epub 2008 Jan 22.
4
Eye movement recordings as an effectiveness indicator of gene therapy in RPE65-deficient canines: implications for the ocular motor system.眼动记录作为RPE65基因缺陷犬基因治疗有效性的指标:对眼动系统的影响
Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2865-75. doi: 10.1167/iovs.05-1233.
5
Tenotomy does not affect saccadic velocities: support for the "small-signal" gain hypothesis.肌腱切断术不影响扫视速度:对“小信号”增益假说的支持。
Vision Res. 2006 Jul;46(14):2259-67. doi: 10.1016/j.visres.2006.01.008. Epub 2006 Feb 23.
6
Ocular motor outcomes after bilateral and unilateral infantile cataracts.双侧和单侧婴儿白内障后的眼球运动结果
Vision Res. 2006 Mar;46(6-7):940-52. doi: 10.1016/j.visres.2005.09.039. Epub 2005 Nov 11.
7
Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness.在儿童失明犬模型中,通过单剂量重组腺相关病毒介导的基因转移至视网膜实现视杆和视锥视觉的长期恢复。
Mol Ther. 2005 Dec;12(6):1072-82. doi: 10.1016/j.ymthe.2005.08.008. Epub 2005 Oct 14.
8
Horizontal rectus muscle tenotomy in children with infantile nystagmus syndrome: a pilot study.儿童先天性眼球震颤综合征水平直肌切断术:一项初步研究。
J AAPOS. 2004 Dec;8(6):539-48. doi: 10.1016/j.jaapos.2004.08.005.
9
Tenotomy and congenital nystagmus: a failure to answer the wrong question.
Vision Res. 2004 Dec;44(26):3091-4; author reply 3094-8. doi: 10.1016/j.visres.2004.07.010.
10
Characteristics of braking saccades in congenital nystagmus.
Doc Ophthalmol. 2003 Sep;107(2):137-54. doi: 10.1023/a:1026258830476.